Author:
Guldogan Emek,Yagin Fatma Hilal,Pinar Abdulvahap,Colak Cemil,Kadry Seifedine,Kim Jungeun
Abstract
AbstractCardiovascular diseases (CVDs) are a serious public health issue that affects and is responsible for numerous fatalities and impairments. Ischemic heart disease (IHD) is one of the most prevalent and deadliest types of CVDs and is responsible for 45% of all CVD-related fatalities. IHD occurs when the blood supply to the heart is reduced due to narrowed or blocked arteries, which causes angina pectoris (AP) chest pain. AP is a common symptom of IHD and can indicate a higher risk of heart attack or sudden cardiac death. Therefore, it is important to diagnose and treat AP promptly and effectively. To forecast AP in women, we constructed a novel artificial intelligence (AI) method employing the tree-based algorithm known as an Explainable Boosting Machine (EBM). EBM is a machine learning (ML) technique that combines the interpretability of linear models with the flexibility and accuracy of gradient boosting. We applied EBM to a dataset of 200 female patients, 100 with AP and 100 without AP, and extracted the most relevant features for AP prediction. We then evaluated the performance of EBM against other AI methods, such as Logistic Regression (LR), Categorical Boosting (CatBoost), eXtreme Gradient Boosting (XGBoost), Adaptive Boosting (AdaBoost), and Light Gradient Boosting Machine (LightGBM). We found that EBM was the most accurate and well-balanced technique for forecasting AP, with accuracy (0.925) and Youden's index (0.960). We also looked at the global and local explanations provided by EBM to better understand how each feature affected the prediction and how each patient was classified. Our research showed that EBM is a useful AI method for predicting AP in women and identifying the risk factors related to it. This can help clinicians to provide personalized and evidence-based care for female patients with AP.
Publisher
Springer Science and Business Media LLC
Reference59 articles.
1. Rehman, S., Rehman, E., Ikram, M. & Jianglin, Z. Cardiovascular disease (CVD): Assessment, prediction and policy implications. BMC Public Health 21, 1–14 (2021).
2. Masoudkabir, F. et al. Shared lifestyle-related risk factors of cardiovascular disease and cancer: Evidence for joint prevention. Sci. World J. 2023, 240 (2023).
3. Battineni, G., Sagaro, G. G., Chintalapudi, N. & Amenta, F. The benefits of telemedicine in personalized prevention of cardiovascular diseases (CVD): A systematic review. J. Pers. Med. 11, 658 (2021).
4. Khan, M. A. et al. Global epidemiology of ischemic heart disease: Results from the global burden of disease study. Cureus 12, 9349 (2020).
5. Peer, N., Baatiema, L. & Kengne, A.-P. Ischaemic heart disease, stroke, and their cardiometabolic risk factors in Africa: Current challenges and outlook for the future. Expert Rev. Cardiovasc. Ther. 19, 129–140 (2021).
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献